| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 80.919 | 105.982 | 108.020 | 136.482 | 131.008 | 246.346 | 467.223 | 510.428 | 590.209 | 872.998 |
| Total Income - EUR | 106.824 | 105.983 | 108.020 | 145.946 | 206.250 | 307.288 | 522.611 | 561.631 | 636.355 | 926.565 |
| Total Expenses - EUR | 90.605 | 84.593 | 73.110 | 112.888 | 197.887 | 272.043 | 349.940 | 420.375 | 480.226 | 617.017 |
| Gross Profit/Loss - EUR | 16.219 | 21.390 | 34.910 | 33.058 | 8.363 | 35.245 | 172.671 | 141.256 | 156.129 | 309.547 |
| Net Profit/Loss - EUR | 13.691 | 18.230 | 33.643 | 31.696 | 7.055 | 33.497 | 168.850 | 137.414 | 148.171 | 261.566 |
| Employees | 3 | 3 | 3 | 3 | 6 | 7 | 7 | 8 | 7 | 7 |
Check the financial reports for the company - Venus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.760 | 3.179 | 1.296 | 496.110 | 490.980 | 402.204 | 316.105 | 245.816 | 260.885 | 743.943 |
| Current Assets | 30.429 | 19.970 | 54.232 | 45.099 | 1.334 | 49.676 | 87.737 | 145.246 | 201.674 | 198.130 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.674 | 15.077 | 51.169 | 16.871 | 0 | 1.143 | 58.624 | 143.422 | 170.833 | 172.975 |
| Cash | 20.755 | 4.892 | 3.063 | 28.228 | 1.334 | 48.533 | 29.113 | 1.824 | 30.841 | 25.155 |
| Shareholders Funds | 31.446 | 18.834 | 52.159 | 82.898 | 33.802 | 56.197 | 169.553 | 138.314 | 286.308 | 269.995 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 3.743 | 4.314 | 3.369 | 350.491 | 116.195 | 116.339 | 16.371 | 84.281 | 13.771 | 562.049 |
| Income in Advance | 0 | 0 | 0 | 107.820 | 342.317 | 279.344 | 217.919 | 168.467 | 162.482 | 110.030 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Venus Med Srl